Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list

Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list

Source: 
Fierce Pharma
snippet: 

Add Novartis to the list of biopharma giants that have filed lawsuits against the U.S. government as a reaction to the Inflation Reduction Act (IRA). 

The company filed its case Friday in New Jersey federal court, three days after the Centers for Medicare & Medicaid Services (CMS) revealed that Novartis’ heart failure treatment Entresto was among 10 drugs subject to price negotiations in 2026.